The contraceptive use of depot medroxyprogesterone acetate
- PMID: 8616981
- DOI: 10.1097/00003081-199538040-00020
The contraceptive use of depot medroxyprogesterone acetate
Abstract
PIP: Depot medroxyprogesterone acetate (DMPA) was the first popular long-acting progestogen-only contraceptive, and is used by more than nine million women worldwide. It is one of the most convenient and effective, yet readily reversible methods of contraception. Although application was first submitted to the US Food and Drug Administration in 1967 for approval to market DMPA as a contraceptive, final approval only came years later in late 1992. DMPA is now approved for marketing as a contraceptive in more than 100 countries, mainly as Depo-Provera for intramuscular use in a 150 mg dose, although several generic products are available in many countries. Many clinicians have access to DMPA as a contraceptive for the first time, and most are aware of the substantial controversy surrounding its use. This paper discusses the role of DMPA in the current array of contraceptive choices, offering guidance for the common clinical problems which may present with use. Sections cover dosage, administration, and contraceptive action; advantages and disadvantages of DMPA; controversies and DMPA; acceptability; and indications and contraindications for use
Similar articles
-
Depo Provera. Position paper on clinical use, effectiveness and side effects.Br J Fam Plann. 1999 Jul;25(2):69-76. Br J Fam Plann. 1999. PMID: 10454658 Review.
-
The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?JAMA. 1983 Jun 3;249(21):2922-8. JAMA. 1983. PMID: 6221125
-
Drug regulation in the United States and the United Kingdom: the Depo-Provera story.Ann Intern Med. 1987 Jun;106(6):886-91. doi: 10.7326/0003-4819-106-6-886. Ann Intern Med. 1987. PMID: 2953290
-
Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.Contraception. 1996 Jun;53(6):357-61. doi: 10.1016/0010-7824(96)00085-6. Contraception. 1996. PMID: 8773423 Clinical Trial.
-
Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge.Drug Saf. 1996 Sep;15(3):212-8. doi: 10.2165/00002018-199615030-00006. Drug Saf. 1996. PMID: 8879975 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources